Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 172 articles:
HTML format



Single Articles


    January 2021
  1. MOUSTAFA D, Elwahed MRA, Elsaid HH, Parvin JD, et al
    Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells.
    PLoS One. 2021;16:e0235025.
    PubMed     Abstract available


  2. GALILI B, Tekpli X, Kristensen VN, Yakhini Z, et al
    Efficient gene expression signature for a breast cancer immuno-subtype.
    PLoS One. 2021;16:e0245215.
    PubMed     Abstract available


  3. BHANDARI D, Shibanuma A, Kiriya J, Hirachan S, et al
    Factors associated with breast cancer screening intention in Kathmandu Valley, Nepal.
    PLoS One. 2021;16:e0245856.
    PubMed     Abstract available


  4. ALLMAN R, Spaeth E, Lai J, Gross SJ, et al
    A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score.
    PLoS One. 2021;16:e0245375.
    PubMed     Abstract available


  5. SAFI N, Saunders C, Hayen A, Anazodo A, et al
    Gestational breast cancer in New South Wales: A population-based linkage study of incidence, management, and outcomes.
    PLoS One. 2021;16:e0245493.
    PubMed     Abstract available


  6. ELLINGJORD-DALE M, Papadimitriou N, Katsoulis M, Yee C, et al
    Coffee consumption and risk of breast cancer: A Mendelian randomization study.
    PLoS One. 2021;16:e0236904.
    PubMed     Abstract available


  7. SALGUERO-ARANDA C, Sancho-Mensat D, Canals-Lorente B, Sultan S, et al
    Expression of Concern: STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
    PLoS One. 2021;16:e0246415.
    PubMed    


  8. NIEF C, Morhard R, Chelales E, Adrianzen Alvarez D, et al
    Polymer-assisted intratumoral delivery of ethanol: Preclinical investigation of safety and efficacy in a murine breast cancer model.
    PLoS One. 2021;16:e0234535.
    PubMed     Abstract available


  9. BOUJEMAA M, Hamdi Y, Mejri N, Romdhane L, et al
    Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
    PLoS One. 2021;16:e0245362.
    PubMed     Abstract available


  10. CHIN CH, Tseng LM, Chao TC, Wang TJ, et al
    Self-care as a mediator between symptom-management self-efficacy and quality of life in women with breast cancer.
    PLoS One. 2021;16:e0246430.
    PubMed     Abstract available


  11. XU S, Wang H, Liu Y, Zhang C, et al
    Hair chemicals may increase breast cancer risk: A meta-analysis of 210319 subjects from 14 studies.
    PLoS One. 2021;16:e0243792.
    PubMed     Abstract available


  12. OLIVEIRA NPD, Cancela MC, Martins LFL, de Souza DLB, et al
    Spatial distribution of advanced stage diagnosis and mortality of breast cancer: Socioeconomic and health service offer inequalities in Brazil.
    PLoS One. 2021;16:e0246333.
    PubMed     Abstract available


  13. ZHOU Y, Yuan Y, Li L, Wang X, et al
    HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer.
    PLoS One. 2021;16:e0245832.
    PubMed     Abstract available


  14. HONG JH, Goo JM, Moon HG, Chang JM, et al
    Usefulness of staging chest-CT in patients with operable breast cancer.
    PLoS One. 2021;16:e0246563.
    PubMed     Abstract available


  15. BAR H, Bang S
    A mixture model to detect edges in sparse co-expression graphs with an application for comparing breast cancer subtypes.
    PLoS One. 2021;16:e0246945.
    PubMed     Abstract available


  16. ZHANG H, Zhang LQ, Yang CC, Li J, et al
    The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling.
    PLoS One. 2021;16:e0245876.
    PubMed     Abstract available


  17. SCIMONE MT, Krishnamurthy S, Maguluri G, Preda D, et al
    Assessment of breast cancer surgical margins with multimodal optical microscopy: A feasibility clinical study.
    PLoS One. 2021;16:e0245334.
    PubMed     Abstract available


  18. YANAI H, Yoshikawa K, Ishida M, Tsuta K, et al
    Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study.
    PLoS One. 2021;16:e0245725.
    PubMed     Abstract available


  19. ASADI M, Ahmadi N, Ahmadvand S, Jafari AA, et al
    Investigation of olfactory receptor family 51 subfamily j member 1 (OR51J1) gene susceptibility as a potential breast cancer-associated biomarker.
    PLoS One. 2021;16:e0246752.
    PubMed     Abstract available


  20. PHAM DX, Ho TH, Bui TD, Ho-Pham LT, et al
    Trends in breast cancer incidence in Ho Chi Minh City 1996-2015: A registry-based study.
    PLoS One. 2021;16:e0246800.
    PubMed     Abstract available


  21. JACKSON C, Freeman ALJ, Szlamka Z, Spiegelhalter DJ, et al
    The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis.
    PLoS One. 2021;16:e0246441.
    PubMed     Abstract available


  22. SANDOVAL RL, Leite ACR, Barbalho DM, Assad DX, et al
    Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis.
    PLoS One. 2021;16:e0247363.
    PubMed     Abstract available


  23. NAFIE E, Lolarga J, Lam B, Guo J, et al
    Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1.
    PLoS One. 2021;16:e0247652.
    PubMed     Abstract available


  24. WANANDI SI, Limanto A, Yunita E, Syahrani RA, et al
    Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
    PLoS One. 2021;16:e0247694.
    PubMed     Abstract available


  25. AL-SALEH K, Salah T, Arafah M, Husain S, et al
    Prognostic significance of estrogen, progesterone and HER2 receptors' status conversion following neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from a tertiary Cancer Center in Saudi Arabia.
    PLoS One. 2021;16:e0247802.
    PubMed     Abstract available


  26. LUO HB, Liu YY, Wang CH, Qing HM, et al
    Radiomic features of axillary lymph nodes based on pharmacokinetic modeling DCE-MRI allow preoperative diagnosis of their metastatic status in breast cancer.
    PLoS One. 2021;16:e0247074.
    PubMed     Abstract available


  27. OLSEN KS, Holden M, Thalabard JC, Rasmussen Busund LT, et al
    Global blood gene expression profiles following a breast cancer diagnosis-Clinical follow-up in the NOWAC post-genome cohort.
    PLoS One. 2021;16:e0246650.
    PubMed     Abstract available


  28. RAHIMZADEH S, Burczynska B, Ahmadvand A, Sheidaei A, et al
    Geographical and socioeconomic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data.
    PLoS One. 2021;16:e0248723.
    PubMed     Abstract available


  29. GRANQVIST V, Holmgren C, Larsson C
    Induction of interferon-beta and interferon signaling by TRAIL and Smac mimetics via caspase-8 in breast cancer cells.
    PLoS One. 2021;16:e0248175.
    PubMed     Abstract available


  30. UMAMAHESWARAN G, Kadambari D, Muthuvel SK, Kumar NAN, et al
    Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer.
    PLoS One. 2021;16:e0247989.
    PubMed     Abstract available


  31. LOURO J, Roman M, Posso M, Vazquez I, et al
    Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
    PLoS One. 2021;16:e0248930.
    PubMed     Abstract available


  32. KOOP Y, Dobbe L, Maas AHEM, van Spronsen DJ, et al
    Oncology professionals' perspectives towards cardiac surveillance in breast cancer patients with high cardiotoxicity risk: A qualitative study.
    PLoS One. 2021;16:e0249067.
    PubMed     Abstract available


  33. GONG Z, Chen J, Wang J, Liu S, et al
    Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry.
    PLoS One. 2021;16:e0249229.
    PubMed     Abstract available


  34. KLINGEN TA, Chen Y, Aas H, Wik E, et al
    Fibulin-2 expression associates with vascular invasion and patient survival in breast cancer.
    PLoS One. 2021;16:e0249767.
    PubMed     Abstract available


  35. MADUT A, Fuchsova V, Man H, Askar S, et al
    Increased prevalence of obstructive sleep apnea in women diagnosed with endometrial or breast cancer.
    PLoS One. 2021;16:e0249099.
    PubMed     Abstract available


  36. AGUIRRE-CAMACHO A, Hidalgo B, Gonzalez-Cuevas G
    Fear of breast cancer among young Spanish women: Factor structure and psychometric properties of the Champion breast cancer fear scale.
    PLoS One. 2021;16:e0249562.
    PubMed     Abstract available


  37. LI J, Zhou Z, Dong J, Fu Y, et al
    Predicting breast cancer 5-year survival using machine learning: A systematic review.
    PLoS One. 2021;16:e0250370.
    PubMed     Abstract available


  38. CHAINITIKUN S, Espinosa Fernandez JR, Long JP, Iwase T, et al
    Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review.
    PLoS One. 2021;16:e0250057.
    PubMed     Abstract available


  39. NGUYEN HOANG AT, Hoe KL, Lee SJ
    CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells.
    PLoS One. 2021;16:e0246264.
    PubMed     Abstract available


  40. NISHIDA-FUKUDA H, Tokuhiro K, Ando Y, Matsushita H, et al
    Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines.
    PLoS One. 2021;16:e0249912.
    PubMed     Abstract available


  41. NERSISYAN S, Galatenko A, Galatenko V, Shkurnikov M, et al
    miRGTF-net: Integrative miRNA-gene-TF network analysis reveals key drivers of breast cancer recurrence.
    PLoS One. 2021;16:e0249424.
    PubMed     Abstract available


  42. SATPATHY S, Patra A, Hussain MD, Kazi M, et al
    A fraction of Pueraria tuberosa extract, rich in antioxidant compounds, alleviates ovariectomized-induced osteoporosis in rats and inhibits growth of breast and ovarian cancer cells.
    PLoS One. 2021;16:e0240068.
    PubMed     Abstract available


  43. HSIANG YP, Wang YT, Huang KS, Huang TY, et al
    Facile production of chlorophyllides using recombinant CrCLH1 and their cytotoxicity towards multidrug resistant breast cancer cell lines.
    PLoS One. 2021;16:e0250565.
    PubMed     Abstract available


  44. YANG C, He XF
    Evaluation of association studies and a systematic review and meta-analysis of CYP1A1 T3801C and A2455G polymorphisms in breast cancer risk.
    PLoS One. 2021;16:e0249632.
    PubMed     Abstract available


  45. AHMED SH, Espinoza-Sanchez NA, El-Damen A, Fahim SA, et al
    Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer.
    PLoS One. 2021;16:e0250642.
    PubMed     Abstract available


  46. HO PJ, Yeoh YS, Miao H, Lim SH, et al
    Cohort profile: The Singapore Breast Cancer Cohort (SGBCC), a multi-center breast cancer cohort for evaluation of phenotypic risk factors and genetic markers.
    PLoS One. 2021;16:e0250102.
    PubMed     Abstract available


  47. TOKUNAGA H, Iida K, Hozawa A, Ogishima S, et al
    Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
    PLoS One. 2021;16:e0236907.
    PubMed     Abstract available


  48. HOLTDIRK F, Mehnert A, Weiss M, Mayer J, et al
    Results of the Optimune trial: A randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors.
    PLoS One. 2021;16:e0251276.
    PubMed     Abstract available


  49. VIJAYASARVESWARI V, Andrew AM, Jusoh M, Ahmad RB, et al
    Correction: Multi-stage feature selection (MSFS) algorithm for UWB-based early breast cancer size prediction.
    PLoS One. 2021;16:e0251679.
    PubMed     Abstract available


  50. ELOBAID Y, Aamir M, Grivna M, Suliman A, et al
    Breast cancer survival and its prognostic factors in the United Arab Emirates: A retrospective study.
    PLoS One. 2021;16:e0251118.
    PubMed     Abstract available


  51. PILLAI SG, Siddappa CM, Ma C, Snider J, et al
    A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.
    PLoS One. 2021;16:e0246139.
    PubMed     Abstract available


  52. SAKATA-MATSUZAWA M, Denda-Nagai K, Fujihira H, Noji M, et al
    Glycans unique to the relapse-prone subset within triple-negative breast cancer as revealed by lectin array-based analysis of surgical specimens.
    PLoS One. 2021;16:e0250747.
    PubMed     Abstract available


  53. CHA YJ, Kim D, Bae SJ, Ahn SG, et al
    The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
    PLoS One. 2021;16:e0250986.
    PubMed     Abstract available


  54. RAGO M, Placidi L, Polsoni M, Rambaldi G, et al
    Evaluation of a generalized knowledge-based planning performance for VMAT irradiation of breast and locoregional lymph nodes-Internal mammary and/or supraclavicular regions.
    PLoS One. 2021;16:e0245305.
    PubMed     Abstract available


  55. YAMAMURO M, Asai Y, Hashimoto N, Yasuda N, et al
    The effect of breast density on the missed lesion rate in screening digital mammography determined using an adjustable-density breast phantom tailored to Japanese women.
    PLoS One. 2021;16:e0245060.
    PubMed     Abstract available


  56. LEE SB, Kim H, Kim J, Chung IY, et al
    Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy.
    PLoS One. 2021;16:e0251597.
    PubMed     Abstract available


  57. MA S, Shepard DS, Ritter GA, Martell RE, et al
    Cost sharing for breast cancer hormone therapy: How do dual eligible patients' copayment impact adherence.
    PLoS One. 2021;16:e0250967.
    PubMed     Abstract available


  58. VELAZQUEZ FN, Zhang L, Viscardi V, Trocchia C, et al
    Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer.
    PLoS One. 2021;16:e0252311.
    PubMed     Abstract available


  59. KIM HS, Kim MG, Min KW, Jung US, et al
    High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
    PLoS One. 2021;16:e0252052.
    PubMed     Abstract available


  60. NG DY, Tudor Car L, Ng MJM, Lu J, et al
    Identifying barriers to early presentation in patients with locally advanced breast cancer (LABC) in Northern Singapore: Qualitative study.
    PLoS One. 2021;16:e0252008.
    PubMed     Abstract available


  61. YOSHIKAWA K, Ishida M, Yanai H, Tsuta K, et al
    Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients.
    PLoS One. 2021;16:e0253176.
    PubMed     Abstract available


  62. LEE J, Kang BJ, Kim SH
    Usefulness of postoperative surveillance MR for women after breast-conservation therapy: Focusing on MR features of early and late recurrent breast cancer.
    PLoS One. 2021;16:e0252476.
    PubMed     Abstract available


  63. AKLILU S, Bain C, Bansil P, de Sanjose S, et al
    Evaluation of diagnostic ultrasound use in a breast cancer detection strategy in Northern Peru.
    PLoS One. 2021;16:e0252902.
    PubMed     Abstract available


  64. PODUVAL D, Sichmanova Z, Straume AH, Lonning PE, et al
    Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer.
    PLoS One. 2021;16:e0253361.
    PubMed     Abstract available


  65. KANG Z, Chen S, Shi L, He Y, et al
    Predictors of heart and lung dose in left-sided breast cancer treated with VMAT relative to 3D-CRT: A retrospective study.
    PLoS One. 2021;16:e0252552.
    PubMed     Abstract available


  66. WATANABE T, Oba T, Tanimoto K, Shibata T, et al
    Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
    PLoS One. 2021;16:e0252822.
    PubMed     Abstract available


  67. AL-KEILANI MS, Elstaty RI, Alqudah MA, Alkhateeb AM, et al
    Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index.
    PLoS One. 2021;16:e0252616.
    PubMed     Abstract available


  68. ZHU L, Cui K, Weng L, Yu P, et al
    A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
    PLoS One. 2021;16:e0249174.
    PubMed     Abstract available


  69. DING H, Buzzard GW, Huang S, Sehorn MG, et al
    MICA-G129R: A bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cells.
    PLoS One. 2021;16:e0252662.
    PubMed     Abstract available



  70. Retraction: AIB1 Cooperates with ERalpha to Promote Epithelial Mesenchymal Transition in Breast Cancer through SNAI1 Activation.
    PLoS One. 2021;16:e0252791.
    PubMed    


  71. OSEI-AFRIYIE S, Addae AK, Oppong S, Amu H, et al
    Breast cancer awareness, risk factors and screening practices among future health professionals in Ghana: A cross-sectional study.
    PLoS One. 2021;16:e0253373.
    PubMed     Abstract available


  72. HSU SN, Hui EWE, Liu M, Wu D, et al
    Revealing nuclear receptor hub modules from Basal-like breast cancer expression networks.
    PLoS One. 2021;16:e0252901.
    PubMed     Abstract available


  73. SALAS M, Henderson M, Sundararajan M, Tu N, et al
    Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review.
    PLoS One. 2021;16:e0252925.
    PubMed     Abstract available


  74. ALMUHTASEB MIA, Alby F, Zucchermaglio C, Fatigante M, et al
    Social support for breast cancer patients in the occupied Palestinian territory.
    PLoS One. 2021;16:e0252608.
    PubMed     Abstract available


  75. WIELEMA M, Sijens PE, Dijkstra H, De Bock GH, et al
    Diffusion weighted imaging of the breast: Performance of standardized breast tumor tissue selection methods in clinical decision making.
    PLoS One. 2021;16:e0245930.
    PubMed     Abstract available


  76. VIVES N, Farre A, Ibanez-Sanz G, Vidal C, et al
    Text messaging as a tool to improve cancer screening programs (M-TICS Study): A randomized controlled trial protocol.
    PLoS One. 2021;16:e0245806.
    PubMed     Abstract available


  77. LI Z, Zhang J, Zou W, Xu Q, et al
    The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism is associated with breast cancer subtype susceptibility in southwestern China.
    PLoS One. 2021;16:e0254267.
    PubMed     Abstract available


  78. KENNEY J, Ndoye A, Lamar JM, DiPersio CM, et al
    Comparative use of CRISPR and RNAi to modulate integrin alpha3beta1 in triple negative breast cancer cells reveals that some pro-invasive/pro-metastatic alpha3beta1 functions are independent of global regulation of the transcriptome.
    PLoS One. 2021;16:e0254714.
    PubMed     Abstract available


  79. YANG J, Virostko J, Hormuth DA 2nd, Liu J, et al
    An experimental-mathematical approach to predict tumor cell growth as a function of glucose availability in breast cancer cell lines.
    PLoS One. 2021;16:e0240765.
    PubMed     Abstract available


  80. KIM H, Kwon S, Son SM, Jeong E, et al
    Tailored approach to the choice of long-term vascular access in breast cancer patients.
    PLoS One. 2021;16:e0255004.
    PubMed     Abstract available


  81. LOTHONG M, Sakares W, Rojsitthisak P, Tanikawa C, et al
    Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway.
    PLoS One. 2021;16:e0255179.
    PubMed     Abstract available


  82. RATH S, Elamarthi P, Parab P, Gulia S, et al
    Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.
    PLoS One. 2021;16:e0253722.
    PubMed     Abstract available


  83. KING L, Flaus A, Holian E, Golden A, et al
    Survival outcomes are associated with genomic instability in luminal breast cancers.
    PLoS One. 2021;16:e0245042.
    PubMed     Abstract available


  84. KIM JJ, Liang W, Kang CC, Pegram MD, et al
    Single-cell immunoblotting resolves estrogen receptor-alpha isoforms in breast cancer.
    PLoS One. 2021;16:e0254783.
    PubMed     Abstract available


  85. AHMED F, Adnan M, Malik A, Tariq S, et al
    Perception of breast cancer risk factors: Dysregulation of TGF-beta/miRNA axis in Pakistani females.
    PLoS One. 2021;16:e0255243.
    PubMed     Abstract available


  86. DANTAS DE ARAUJO SANTOS CAMARG, Dos Santos J, Simoes TC, Carvalho JBL, et al
    Mortality due to breast cancer in a region of high socioeconomic vulnerability in Brazil: Analysis of the effect of age-period and cohort.
    PLoS One. 2021;16:e0255935.
    PubMed     Abstract available


  87. NORDIN FJ, Pearanpan L, Chan KM, Kumolosasi E, et al
    Immunomodulatory potential of Clinacanthus nutans extracts in the co-culture of triple-negative breast cancer cells, MDA-MB-231, and THP-1 macrophages.
    PLoS One. 2021;16:e0256012.
    PubMed     Abstract available


  88. ASTARITA EM, Maloney SM, Hoover CA, Berkeley BJ, et al
    Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells.
    PLoS One. 2021;16:e0255738.
    PubMed     Abstract available


  89. SUN Z, Nyberg R, Wu Y, Bernard B, et al
    Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.
    PLoS One. 2021;16:e0247238.
    PubMed     Abstract available


  90. PORCIELLO G, Montagnese C, Crispo A, Grimaldi M, et al
    Correction: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial.
    PLoS One. 2021;16:e0256944.
    PubMed     Abstract available


  91. HEENAYE-MAMODE KHAN M, Boodoo-Jahangeer N, Dullull W, Nathire S, et al
    Multi- class classification of breast cancer abnormalities using Deep Convolutional Neural Network (CNN).
    PLoS One. 2021;16:e0256500.
    PubMed     Abstract available


  92. ARNEJA J, Brooks JD
    The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.
    PLoS One. 2021;16:e0256536.
    PubMed     Abstract available


  93. AHN HS, Kim SH, Kim JY, Park CS, et al
    Image quality and diagnostic value of diffusion-weighted breast magnetic resonance imaging: Comparison of acquired and computed images.
    PLoS One. 2021;16:e0247379.
    PubMed     Abstract available


  94. XIA LY, Xu WY, Hu QL
    The different outcomes between breast-conserving surgery plus radiotherapy and mastectomy in metaplastic breast cancer: A population-based study.
    PLoS One. 2021;16:e0256893.
    PubMed     Abstract available


  95. JANK P, Gehlhaar C, Lederer B, Fontanella C, et al
    Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
    PLoS One. 2021;16:e0257142.
    PubMed     Abstract available


  96. WOO J, Kim JB, Cho T, Yoo EH, et al
    Selenium inhibits growth of trastuzumab-resistant human breast cancer cells via downregulation of Akt and beclin-1.
    PLoS One. 2021;16:e0257298.
    PubMed     Abstract available


  97. ALAM NE, Islam MS, Ullah H, Molla MT, et al
    Evaluation of knowledge, awareness and attitudes towards breast cancer risk factors and early detection among females in Bangladesh: A hospital based cross-sectional study.
    PLoS One. 2021;16:e0257271.
    PubMed     Abstract available


  98. TESHOME B, Trabitzsch J, Afework T, Addissie A, et al
    Perceived barriers to timely treatment initiation and social support status among women with breast cancer in Ethiopia.
    PLoS One. 2021;16:e0257163.
    PubMed     Abstract available


  99. YOSHIKAWA K, Ishida M, Yanai H, Tsuta K, et al
    Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer.
    PLoS One. 2021;16:e0257860.
    PubMed     Abstract available


  100. MEKONEN S, Ibrahim M, Astatkie H, Abreha A, et al
    Exposure to organochlorine pesticides as a predictor to breast cancer: A case-control study among Ethiopian women.
    PLoS One. 2021;16:e0257704.
    PubMed     Abstract available


  101. CASELLI E, Pelliccia C, Teti V, Bellezza G, et al
    Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCR.
    PLoS One. 2021;16:e0255580.
    PubMed     Abstract available


  102. CIRIA-SUAREZ L, Jimenez-Fonseca P, Palacin-Lois M, Antonanzas-Basa M, et al
    Breast cancer patient experiences through a journey map: A qualitative study.
    PLoS One. 2021;16:e0257680.
    PubMed     Abstract available


  103. OLAYA-GALAN NN, Salas-Cardenas SP, Rodriguez-Sarmiento JL, Ibanez-Pinilla M, et al
    Risk factor for breast cancer development under exposure to bovine leukemia virus in Colombian women: A case-control study.
    PLoS One. 2021;16:e0257492.
    PubMed     Abstract available


  104. HADJIPANTELI A, Polyviou P, Kyriakopoulos I, Genagritis M, et al
    Comparison of two-view versus single-view digital breast tomosynthesis and 2D-mammography in breast cancer surveillance imaging.
    PLoS One. 2021;16:e0256514.
    PubMed     Abstract available


  105. SANI L, Vispa A, Loretoni R, Duranti M, et al
    Breast lesion detection through MammoWave device: Empirical detection capability assessment of microwave images' parameters.
    PLoS One. 2021;16:e0250005.
    PubMed     Abstract available


  106. JARM K, Kadivec M, Sval C, Hertl K, et al
    Quality assured implementation of the Slovenian breast cancer screening programme.
    PLoS One. 2021;16:e0258343.
    PubMed     Abstract available


  107. SAKSORNCHAI K, Jaruthien T, Nantavithya C, Shotelersuk K, et al
    Long-term results of hypofractionation with concomitant boost in patients with early breast cancer: A prospective study.
    PLoS One. 2021;16:e0258186.
    PubMed     Abstract available


  108. GARCIA MT, Mota BS, Cardoso N, Martimbianco ALC, et al
    Accuracy of frozen section in intraoperative margin assessment for breast-conserving surgery: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248768.
    PubMed     Abstract available


  109. XIE Y, Guo B, Zhang R
    Cost-effectiveness analysis of radiotherapy techniques for whole breast irradiation.
    PLoS One. 2021;16:e0248220.
    PubMed     Abstract available


  110. MOHAMED RI, Bargal SA, Mekawy AS, El-Shiekh I, et al
    The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine.
    PLoS One. 2021;16:e0247837.
    PubMed     Abstract available


    January 2020
  111. HONG S, Youk T, Lee SJ, Kim KM, et al
    Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
    PLoS One. 2020;15:e0234927.
    PubMed     Abstract available


  112. HARATI R, Hafezi S, Mabondzo A, Tlili A, et al
    Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells.
    PLoS One. 2020;15:e0239292.
    PubMed     Abstract available


  113. GUO A, Drake BF, Khan YM, Langabeer Ii JR, et al
    Time-series cardiovascular risk factors and receipt of screening for breast, cervical, and colon cancer: The Guideline Advantage.
    PLoS One. 2020;15:e0236836.
    PubMed     Abstract available


  114. ROSEN S, Brisson BK, Durham AC, Munroe CM, et al
    Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma.
    PLoS One. 2020;15:e0236516.
    PubMed     Abstract available


  115. LELLUPITIYAGE DON SS, Robertson KL, Lin HH, Labriola C, et al
    Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner.
    PLoS One. 2020;15:e0236315.
    PubMed     Abstract available


  116. PORCIELLO G, Montagnese C, Crispo A, Grimaldi M, et al
    Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial.
    PLoS One. 2020;15:e0239803.
    PubMed     Abstract available



  117. Retraction: Role of Activated Rac1/Cdc42 in Mediating Endothelial Cell Proliferation and Tumor Angiogenesis in Breast Cancer.
    PLoS One. 2020;15:e0240575.
    PubMed    



  118. Retraction: Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells.
    PLoS One. 2020;15:e0240574.
    PubMed    


  119. SOLIMAN SSM, Alhamidi TB, Abdin S, Almehdi AM, et al
    Effective targeting of breast cancer cells (MCF7) via novel biogenic synthesis of gold nanoparticles using cancer-derived metabolites.
    PLoS One. 2020;15:e0240156.
    PubMed     Abstract available


  120. DELARMELINA E, Buzelin MA, Souza BS, Souto FM, et al
    High positivity values for bovine leukemia virus in human breast cancer cases from Minas Gerais, Brazil.
    PLoS One. 2020;15:e0239745.
    PubMed     Abstract available


  121. SONG JH, Eum DY, Park SY, Jin YH, et al
    Inhibitory effect of ginsenoside Rg3 on cancer stemness and mesenchymal transition in breast cancer via regulation of myeloid-derived suppressor cells.
    PLoS One. 2020;15:e0240533.
    PubMed     Abstract available


  122. RODRIGUEZ NM, Casanova F, Pages G, Claure L, et al
    Community-based participatory design of a community health worker breast cancer training intervention for South Florida Latinx farmworkers.
    PLoS One. 2020;15:e0240827.
    PubMed     Abstract available



  123. Correction: Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
    PLoS One. 2020;15:e0241089.
    PubMed     Abstract available


  124. MOSAYEBI A, Mojaradi B, Bonyadi Naeini A, Khodadad Hosseini SH, et al
    Modeling and comparing data mining algorithms for prediction of recurrence of breast cancer.
    PLoS One. 2020;15:e0237658.
    PubMed     Abstract available


  125. PARK SH, Jeong YM, Lee HY, Kim EY, et al
    Opportunistic use of chest CT for screening osteoporosis and predicting the risk of incidental fracture in breast cancer patients: A retrospective longitudinal study.
    PLoS One. 2020;15:e0240084.
    PubMed     Abstract available


  126. CHA YJ, Koo JS
    Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
    PLoS One. 2020;15:e0238466.
    PubMed     Abstract available


  127. SHARMA D, Cartar H, Law N, Giles A, et al
    Optimization of microbubble enhancement of hyperthermia for cancer therapy in an in vivo breast tumour model.
    PLoS One. 2020;15:e0237372.
    PubMed     Abstract available


  128. ZHANG C, Zhao J, Niu J, Li D, et al
    New convolutional neural network model for screening and diagnosis of mammograms.
    PLoS One. 2020;15:e0237674.
    PubMed     Abstract available


  129. YEASMEEN T, Kelaher M, Brotherton JML, Malloy MJ, et al
    Understanding the participation of breast screening among women born in predominantly Muslim countries living in Victoria, Australia from record-linkage data.
    PLoS One. 2020;15:e0237341.
    PubMed     Abstract available


  130. DAHMANI Z, Addou-Klouche L, Gizard F, Dahou S, et al
    Metformin partially reverses the inhibitory effect of co-culture with ER-/PR-/HER2+ breast cancer cells on biomarkers of monocyte antitumor activity.
    PLoS One. 2020;15:e0240982.
    PubMed     Abstract available


  131. LEE SB, Gwark SC, Kang CM, Sohn G, et al
    The effects of poloxamer and sodium alginate mixture (Guardix-SG(R)) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study.
    PLoS One. 2020;15:e0238284.
    PubMed     Abstract available


  132. BAIO G, Fabbi M, Cilli M, Rosa F, et al
    Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors.
    PLoS One. 2020;15:e0224414.
    PubMed     Abstract available


  133. ESPANOL AJ, Salem A, Di Bari M, Cristofaro I, et al
    The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype.
    PLoS One. 2020;15:e0226450.
    PubMed     Abstract available


  134. BARTLETT JMS, Bayani J, Kornaga EN, Danaher P, et al
    Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.
    PLoS One. 2020;15:e0238593.
    PubMed     Abstract available


  135. TRACY JK, Adetunji F, Al Kibria GM, Swanberg JE, et al
    Cancer-work management: Hourly and salaried wage women's experiences managing the cancer-work interface following new breast cancer diagnosis.
    PLoS One. 2020;15:e0241795.
    PubMed     Abstract available


  136. BODILY WR, Shirts BH, Walsh T, Gulsuner S, et al
    Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures.
    PLoS One. 2020;15:e0239197.
    PubMed     Abstract available


  137. LUO CY, Natividad RJ, Lalli ML, Asthagiri AR, et al
    Multivariate relationships among nucleus and Golgi properties during fibrillar migration are robust to and unchanged by epithelial-to-mesenchymal transition.
    PLoS One. 2020;15:e0239188.
    PubMed     Abstract available


  138. HUANG JS, Pan HB, Yang TL, Hung BH, et al
    Kinetic patterns of benign and malignant breast lesions on contrast enhanced digital mammogram.
    PLoS One. 2020;15:e0239271.
    PubMed     Abstract available


  139. CUI P, Chen Y, Waili N, Li Y, et al
    Associations of serum C-peptide and insulin-like growth factor binding proteins-3 with breast cancer deaths.
    PLoS One. 2020;15:e0242310.
    PubMed     Abstract available


  140. CRESPO J, Sun H, Wu J, Ding QQ, et al
    Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy.
    PLoS One. 2020;15:e0241775.
    PubMed     Abstract available


  141. BAJAJ R, Tripathi R, Sridhar TS, Korlimarla A, et al
    Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer.
    PLoS One. 2020;15:e0242190.
    PubMed     Abstract available


  142. MO W, Ding Y, Zhao S, Zou D, et al
    Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    PLoS One. 2020;15:e0241924.
    PubMed     Abstract available


  143. LIN H, Wu Y, Liang G, Chen L, et al
    Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
    PLoS One. 2020;15:e0242155.
    PubMed     Abstract available


  144. CHANG TC, Matossian MD, Elliott S, Burks HE, et al
    Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor.
    PLoS One. 2020;15:e0226464.
    PubMed     Abstract available


  145. BERA A, Subramanian M, Karaian J, Eklund M, et al
    Functional role of vitronectin in breast cancer.
    PLoS One. 2020;15:e0242141.
    PubMed     Abstract available


  146. WANANDI SI, Limanto A, Yunita E, Syahrani RA, et al
    In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
    PLoS One. 2020;15:e0240020.
    PubMed     Abstract available


  147. YOSHIKAWA K, Ishida M, Yanai H, Tsuta K, et al
    Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study.
    PLoS One. 2020;15:e0242563.
    PubMed     Abstract available


  148. CHIANG ZC, Chiu YK, Lee CC, Hsu NS, et al
    Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells.
    PLoS One. 2020;15:e0239813.
    PubMed     Abstract available


  149. MATHEWS PM, Robinson SA, Gire A, Baer AN, et al
    Extraglandular ocular involvement and morbidity and mortality in primary Sjogren's Syndrome.
    PLoS One. 2020;15:e0239769.
    PubMed     Abstract available


  150. AFRIN K, Iquebal AS, Karimi M, Souris A, et al
    Directionally dependent multi-view clustering using copula model.
    PLoS One. 2020;15:e0238996.
    PubMed     Abstract available


  151. TESFAW A, Alebachew W, Tiruneh M
    Why women with breast cancer presented late to health care facility in North-west Ethiopia? A qualitative study.
    PLoS One. 2020;15:e0243551.
    PubMed     Abstract available


  152. CARTER KJ, Castro F, Morcos RN
    A method for evaluating breast cancer screening strategies using screen-preventable loss of life.
    PLoS One. 2020;15:e0243113.
    PubMed     Abstract available


  153. ZOU Y, Fineberg S, Pearlman A, Feinman RD, et al
    The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer.
    PLoS One. 2020;15:e0233662.
    PubMed     Abstract available


  154. DE MEULENAERE V, Descamps B, De Wever O, Vanhove C, et al
    In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
    PLoS One. 2020;15:e0243156.
    PubMed     Abstract available


  155. FADDA M, Chappuis PO, Katapodi MC, Pagani O, et al
    Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
    PLoS One. 2020;15:e0240054.
    PubMed     Abstract available


  156. SHI Y, Gong W, Gong X, Wang P, et al
    Genome-wide DNA methylation analysis of breast cancer MCF-7 / Taxol cells with MeDIP-Seq.
    PLoS One. 2020;15:e0241515.
    PubMed     Abstract available


  157. MAO Y, Zhao Y, Zhang Y, Yang H, et al
    In-depth characterization and comparison of the N-glycosylated proteome of two-dimensional- and three-dimensional-cultured breast cancer cells and xenografted tumors.
    PLoS One. 2020;15:e0243789.
    PubMed     Abstract available


  158. NAGHIBI L, Yazdani M, Momtazi-Borojeni AA, Razazan A, et al
    Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer.
    PLoS One. 2020;15:e0243550.
    PubMed     Abstract available


  159. DE LA CRUZ-KU G, Chambergo-Michilot D, Torres-Roman JS, Rebaza P, et al
    Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer.
    PLoS One. 2020;15:e0243447.
    PubMed     Abstract available


  160. BAR-SELA G, Cohen I, Avisar A, Loven D, et al
    Circulating blood extracellular vesicles as a tool to assess endothelial injury and chemotherapy toxicity in adjuvant cancer patients.
    PLoS One. 2020;15:e0240994.
    PubMed     Abstract available


  161. MOODLEY J, Constant D, Mwaka AD, Scott SE, et al
    Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa.
    PLoS One. 2020;15:e0240788.
    PubMed     Abstract available


  162. MOGAKA JJO, Chimbari MJ
    The mediating effects of public genomic knowledge in precision medicine implementation: A structural equation model approach.
    PLoS One. 2020;15:e0240585.
    PubMed     Abstract available


  163. LI X, Plataniotis KN
    How much off-the-shelf knowledge is transferable from natural images to pathology images?
    PLoS One. 2020;15:e0240530.
    PubMed     Abstract available


  164. CIRIA-SUAREZ L, Jimenez-Fonseca P, Palacin-Lois M, Antonanzas-Basa M, et al
    Ascertaining breast cancer patient experiences through a journey map: A qualitative study protocol.
    PLoS One. 2020;15:e0244355.
    PubMed     Abstract available


  165. WANG L, Wang W, Zeng S, Zheng H, et al
    Construction and validation of a 6-gene nomogram discriminating lung metastasis risk of breast cancer patients.
    PLoS One. 2020;15:e0244693.
    PubMed     Abstract available


  166. ZABALLA O, Perez A, Gomez Inhiesto E, Acaiturri Ayesta T, et al
    Identifying common treatments from Electronic Health Records with missing information. An application to breast cancer.
    PLoS One. 2020;15:e0244004.
    PubMed     Abstract available


  167. MOODLEY J, Williams P, Gohla G, Major P, et al
    Variation in breast cancer grading in 1,636 resections assessed using control charts and in silico kappa.
    PLoS One. 2020;15:e0242656.
    PubMed     Abstract available


  168. MEKONNEN BD
    Breast self-examination practice and associated factors among female healthcare workers in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0241961.
    PubMed     Abstract available


  169. WINNARD PT JR, Vesuna F, Muthukumar S, Raman V, et al
    Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity.
    PLoS One. 2020;15:e0242384.
    PubMed     Abstract available


  170. DE LOS CAMPOS G, Pook T, Gonzalez-Reymundez A, Simianer H, et al
    ANOVA-HD: Analysis of variance when both input and output layers are high-dimensional.
    PLoS One. 2020;15:e0243251.
    PubMed     Abstract available


  171. OSAPOETRA LO, Chan W, Tran W, Kolios MC, et al
    Comparison of methods for texture analysis of QUS parametric images in the characterization of breast lesions.
    PLoS One. 2020;15:e0244965.
    PubMed     Abstract available


  172. TOYODA Y, Tabuchi T, Hama H, Morishima T, et al
    Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
    PLoS One. 2020;15:e0244644.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: